Genpact Limited (G) Operating Margin
- Operating margin · 12 months: Value 14.83%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 14.83% | Operating income / revenue. Period ending 2026-06-30. $778.63M ÷ $5.25B × 100 ≈ 14.83% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 778.63M USD | Operating Income (Loss) |
| Revenue | 5.25B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 1.10B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $778.63M | $5.25B | (m) | (m) | $1.10B | 14.83% |
| 2026-03-31 | $765.09M | $5.16B | (m) | (m) | $1.08B | 14.82% |
| 2025-12-31 | $750.21M | $5.08B | (m) | (m) | $1.05B | 14.77% |
| 2025-09-30 | $744.92M | $5.01B | (m) | (m) | $1.02B | 14.87% |
| 2025-06-30 | $734.93M | $4.93B | (m) | (m) | $999.95M | 14.91% |
| 2025-03-31 | $725.78M | $4.85B | (m) | (m) | $973.20M | 14.96% |
| 2024-12-31 | $702.06M | $4.77B | (m) | (m) | $967.14M | 14.73% |
| 2024-09-30 | $674.62M | $4.66B | (m) | (m) | $955.41M | 14.46% |
| 2024-06-30 | $658.66M | $4.59B | (m) | (m) | $941.82M | 14.35% |
| 2024-03-31 | $645.73M | $4.52B | (m) | (m) | $931.61M | 14.29% |
| 2023-12-31 | $630.86M | $4.48B | (m) | (m) | $913.06M | 14.09% |
| 2023-09-30 | $595.88M | $4.43B | (m) | (m) | $912.20M | 13.44% |
| 2023-06-30 | $561.02M | $4.41B | (m) | (m) | $913.90M | 12.73% |
| 2023-03-31 | $513.39M | $4.39B | (m) | (m) | $917.57M | 11.69% |
| 2022-12-31 | $502.15M | $4.37B | (m) | (m) | $938.38M | 11.49% |
| 2022-09-30 | $486.32M | $4.34B | (m) | (m) | $946.69M | 11.20% |
| 2022-06-30 | $487.77M | $4.25B | (m) | (m) | $931.21M | 11.49% |
| 2022-03-31 | $514.99M | $4.14B | (m) | (m) | $902.28M | 12.43% |
| 2021-12-31 | $509.00M | $4.02B | (m) | (m) | $865.72M | 12.65% |
| 2021-09-30 | $510.13M | $3.90B | (m) | (m) | $828.72M | 13.08% |
| 2021-06-30 | $502.48M | $3.82B | (m) | (m) | $811.10M | 13.15% |
| 2021-03-31 | $455.94M | $3.73B | (m) | (m) | $793.24M | 12.22% |
| 2020-12-31 | $438.72M | $3.71B | (m) | (m) | $789.85M | 11.83% |
| 2020-09-30 | $445.18M | $3.70B | (m) | (m) | $794.64M | 12.03% |
| 2020-06-30 | $434.12M | $3.65B | (m) | (m) | $790.84M | 11.88% |
| 2020-03-31 | $449.96M | $3.63B | (m) | (m) | $800.84M | 12.38% |
| 2019-12-31 | $429.38M | $3.52B | (m) | (m) | $794.90M | 12.20% |
| 2019-09-30 | $420.70M | $3.42B | (m) | (m) | $760.83M | 12.32% |
| 2019-06-30 | $401.14M | $3.27B | (m) | (m) | $734.30M | 12.25% |
| 2019-03-31 | $374.46M | $3.12B | (m) | (m) | $714.16M | 12.00% |
| 2018-12-31 | $348.15M | $3.00B | (m) | (m) | $693.87M | 11.60% |
| 2018-09-30 | $307.96M | (m) | (m) | (m) | $704.49M | (m) |
| 2018-06-30 | $311.86M | (m) | (m) | (m) | $708.51M | (m) |
| 2018-03-31 | $313.29M | (m) | (m) | (m) | $700.10M | (m) |
| 2017-12-31 | $328.63M | (m) | (m) | (m) | $689.85M | (m) |
| 2017-09-30 | $354.67M | (m) | (m) | (m) | $671.57M | (m) |
| 2017-06-30 | $344.34M | (m) | (m) | (m) | $656.44M | (m) |
| 2017-03-31 | $344.25M | (m) | (m) | (m) | $653.74M | (m) |
| 2016-12-31 | $340.78M | (m) | (m) | (m) | $653.03M | (m) |
| 2016-09-30 | $326.13M | (m) | (m) | (m) | $647.73M | (m) |
| 2016-06-30 | $326.35M | (m) | (m) | (m) | $635.48M | (m) |
| 2016-03-31 | $335.76M | (m) | (m) | (m) | $619.51M | (m) |
| 2015-12-31 | $334.19M | (m) | (m) | (m) | $608.11M | (m) |
| 2015-09-30 | $321.61M | $2.42B | (m) | (m) | $609.99M | 13.31% |
| 2015-06-30 | $307.14M | $2.39B | (m) | (m) | $618.41M | 12.87% |
| 2015-03-31 | $290.83M | $2.34B | (m) | (m) | $611.90M | 12.44% |
| 2014-12-31 | $294.03M | $2.28B | (m) | (m) | $585.65M | 12.90% |
| 2014-09-30 | $294.80M | $2.24B | (m) | (m) | $554.54M | 13.18% |
| 2014-06-30 | $307.89M | $2.18B | (m) | (m) | $518.40M | 14.10% |
| 2014-03-31 | $312.82M | $2.16B | (m) | (m) | $494.08M | 14.51% |
| 2013-12-31 | $309.53M | $2.13B | (m) | (m) | $484.81M | 14.52% |
| 2013-09-30 | $308.69M | $2.08B | (m) | (m) | $467.45M | 14.83% |
| 2013-06-30 | $292.68M | $2.04B | (m) | (m) | $468.98M | 14.36% |
| 2013-03-31 | $277.86M | $1.97B | (m) | (m) | $464.83M | 14.10% |
| 2012-12-31 | $264.35M | $1.90B | (m) | (m) | $456.61M | 13.90% |
| 2012-09-30 | $255.48M | $1.84B | (m) | (m) | $445.72M | 13.91% |
| 2012-06-30 | $242.27M | $1.78B | (m) | (m) | $423.05M | 13.65% |
| 2012-03-31 | $230.17M | $1.71B | (m) | (m) | $395.52M | 13.50% |
| 2011-12-31 | $216.24M | $1.60B | (m) | (m) | $357.96M | 13.51% |
| 2011-09-30 | $214.20M | $1.50B | (m) | (m) | $312.69M | 14.29% |
| 2011-06-30 | $199.88M | $1.39B | (m) | (m) | $288.10M | 14.37% |
| 2011-03-31 | $187.11M | $1.30B | (m) | (m) | $276.65M | 14.38% |
| 2010-12-31 | $177.86M | $1.26B | (m) | (m) | $282.10M | 14.13% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $162.18M | $1.12B | (m) | (m) | $265.39M | 14.48% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $133.71M | $1.04B | (m) | (m) | $254.53M | 12.85% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |